The largest database of trusted experimental protocols

6 protocols using cd45 af488

1

Murine Skeletal Muscle Stem Cell Isolation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Both TA muscles from 1 mouse were pooled, finely minced, and digested for 60 minutes at 37°C in DMEM with 0.2% (~5500 U/mL) collagenase type II and 2.5 U/mL dispase II. The resulting digest solution was filtered through a 70 μm cell strainer and then centrifuged at 350g for 5 minutes. Cells were resuspended and incubated for 30 minutes on ice with primary antibodies, including Sca-1-APC (BioLegend clone D7; 108112), CD45-AF488 (BioLegend clone 30-F11; 103121), CD11b-APC (BioLegend clone M1/70; 101212), Ter119-APC (BioLegend clone TER-119; 116212), CD29/β1-integrin-PE (BioLegend clone HMb-1; 102208), and CD184/CXCR-4-BIOTIN (BD Biosciences lot 6336587; 551968). Cells were then washed, centrifuged, and resuspended in PECy7-STREPTAVIDIN secondary antibody (eBioscience, Thermo Fisher Scientific, lot 4290713; 25-4317-82). The stained cells were filtered through a 35 μm cell strainer, propidium iodide viability dye was added (1 μg) (Thermo Fisher Scientific), and FACS was performed using a BD FACSAria III Cell Sorter (BD Biosciences). MuSCs, classified here as APC/FITC (Sca-1, CD11b, Ter119, CD45) double-negative and PE/PECy7 (β1-integrin/CXCR-4) double-positive cells, were sorted into TRIzol reagent (Thermo Fisher Scientific) and stored at –80°C.
+ Open protocol
+ Expand
2

Isolation of Pancreatic Tumor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pancreatic tumors were minced and dissociated into single cells by sequentially incubating them in 1) dissociation media for 1h at 37C with gentle agitation, 2) Trypsin 0.25% for 10 min at 37°C, and 3) ACK lysis buffer (ThermoFisher) for 2 min at room temperature to remove erythrocytes. Dissociation media was prepared freshly as follows: DMEM supplemented with 1 mg/mL Trypsin inhibitor (Gibco), 1 mg/mL Dispase II (Gibco), 1 mg/mL Collagenase IV (Gibco) and 0.025 mg/mL DNAse (Sigma). Final suspensions were passed through a 100 μm nylon mesh to remove aggregates. For labeling, cells were incubated on ice with Mouse Fc Block (BD Biosciences, 1/200) followed by antigen-specific antibodies, in FACS buffer (PBS with 1mM EDTA and 0.5% BSA). Cells were sorted at the Salk Institute FACS core facility on a BD Influx cell sorter. DAPI (Molecular Probes) was used to exclude dead cells. For labeling, the following antibodies were used: CD45-AF488, EPCAM-AF647, and PDGFRα-PE (Biolegend, 1/200).
+ Open protocol
+ Expand
3

Flow Cytometry Analysis of Activated Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The activated/rested cells were plated into a 96-well round bottom plate and pelleted at low speed. Cells were resuspended in chilled media containing titrated HS-131 or HS-198 (in 1% DMSO) and stained for 30 min at RT. Fluorochrome tagged inhibitors and media were washed away with a PBS wash, followed by a PBS wash containing 3% NMS. Surface antibody stains were performed in 3% NMS/PBS for 30 min followed by PBS washes (2×) (Table 2). Samples were analyzed on BD FACSCanto II flow cytometer. Permeabilized samples were prepared as previously described followed by fixation in 4% Formaldehyde/PBS overnight at 4 °C. Minimum gating of 2X105 cells/sample. Sample analysis was performed with Flowing Software and FlowJo.

Flow cytometry antibodies.

AntibodyTarget and fluorManufacturerConcentration
300434CD3- BV421BioLegend1:200
302616CD25-AF488BioLegend1:200
423113Viability-BV421BioLegend1:1000
423102Viability-BV510BioLegend1:1000
310903CD69-FITCBioLegend1:200
302605CD25-PEBioLegend1:200
561105Ly6G-AF488BD Biosciences1:500
103139CD45-BV605BioLegend1:800
563415IA/IE-BV650BD Biosciences1:1500
103121CD45-AF488BioLegend1:1000
300454CD3-AF488BioLegend1:1000
301817CD14-AF488BioLegend1:1000
400625Rat IgG2b Isotype ControlBioLegend1:1000
+ Open protocol
+ Expand
4

Multicolor Flow Cytometry Panel

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD45 AF488 (Biolegend, clone 30-F11, cat 103122), MHC class II tetramer-PE (from the NIH tetramer core facility at Emory, Atlanta, GA), CD4 BUV395 (BD, clone GK1.1, cat 563790), CD8 PerCP-Cy5.5 (Biolegend, clone 53–6.7, cat 100734), CD44 BV650 (Biolegend, clone IM7, cat 1033049), CD11b APC (Biolegend, clone M1/70, cat 101212), CD11c APC (Biolegend, clone N418, cat 117310), NK1.1 APC (Biolegend, clone PK136, cat 108710), B220 APC (Biolegend, clone RA3-62B, cat 103212).
+ Open protocol
+ Expand
5

Multiparameter Flow Cytometry of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were washed in phosphate-buffered saline (PBS) and harvested with Accutase (MilliporeSigma, SCR005) for 10 minutes at room temperature. Dissociated cells were washed once in flow staining buffer (PBS + 1% FBS) and incubated with respective flow antibodies at 4°C for 20 minutes in the dark. Flow cytometry was performed using the following antibodies: CD45/AF488 (BioLegend clone 30-F11, 1:500), Ly6C/PE (BioLegend clone HK1.4, 1:250), Ly6G/APC-Cy7 (BioLegend clone 1A8,1:250), CD11b/PE-Cy7 (BioLegend clone M1/70,1:250), CD274 (PD-L1)/APC (BioLegend clone 10F.9G2, 1:250), and mouse MHC-II (I-A/I-E)/BV711 (BioLegend clone M5/114.15.2, 1:500). DAPI was used as a viability dye for dead cell exclusion. Samples were analyzed on an Attune NxT flow cytometer (Life Technologies, Thermo Fisher Scientific).
+ Open protocol
+ Expand
6

Lipoptosis Quantification in Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cancer cells were cultured alone or with PCW cells for 72 hours. Naïve or LPS-activated PCW were compared. LPS was purchased from InvivoGen (Cat# tlrl-pb5LPS). For activation, PCW were pre-treated with 1μg/ml LPS for 48 hours unless otherwise indicated. Cancer cells were then fixed with 4% PFA and stained with CD45-AF488 (BioLegend, Cat# 103122) as leukocyte marker, Oil Red O (ORO) (Sigma, confirm Cat#) for lipid stain and Hoechst 33342 (Invitrogen, Cat# R37605) as nuclear stain (Supplementary Figures S2A, B). Lipoptosis was quantified by measuring the average area of ORO staining in each cancer cell. Cancer cells were identified as CD45 negative cells. Cancer cell number per field was determined by counting Hoechst 33342 staining per field. Leukocytes were quantified by both areas of Hoechst 33342 staining and CD45-AF488 staining. ORO staining in cancer cells and lymphocytes were differentiated and counted respectively in the entire field. Average area of ORO stain per cancer cell was used as the final measure of lipoptosis quantification (Supplementary Figure S3).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!